Internal Medicine, Gastroenterology · New Haven, CT
NPI
1588648851
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
800 Howard Ave, Yale Physicians Bldg, 4th Fl
New Haven, CT, 06519
Phone (203) 785-7352
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,880
121 services
Medicare patients, 2024
63
Average age 69
Drug cost, 2024
$9.7M
372 prescriptions
Company payments, 2025
$3,884
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pramod K Mistry was code 99232 (hospital e&m - subsequent), 28 times for 12 patients. In total Pramod K Mistry billed 121 services in 14 codes, and Medicare paid $9,880.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 28 | 12 | $61.69 | $1,727 |
| 99221 Hospital E&M - Initial | Facility | 19 | 18 | $67.86 | $1,289 |
By year: 2022 $11K for 154 services; 2023 $8,270 for 106 services; 2024 $9,880 for 121 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pramod K Mistry prescribed most often to Medicare patients was Cerdelga (Eliglustat Tartrate), with 166 prescriptions and refills. In total Pramod K Mistry wrote 372 Medicare prescriptions that cost $9.7M.
Brand drugs: 317 claims; generic drugs: 55 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pramod K Mistry $3,884 ($2,634 in general payments such as food, travel and fees and $1,250 for research) from 2 companies. The largest payer was Genzyme Corporation with $3,884.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 12 | $3,884 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.